BR0114835A - Composições terapêuticas para tratamento de infecção por lawsonia spp - Google Patents
Composições terapêuticas para tratamento de infecção por lawsonia sppInfo
- Publication number
- BR0114835A BR0114835A BR0114835-4A BR0114835A BR0114835A BR 0114835 A BR0114835 A BR 0114835A BR 0114835 A BR0114835 A BR 0114835A BR 0114835 A BR0114835 A BR 0114835A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- therapeutic compositions
- lawsonia intracellularis
- present
- lawsonia
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000001225 therapeutic effect Effects 0.000 title abstract 3
- 241001469654 Lawsonia <weevil> Species 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 241001148567 Lawsonia intracellularis Species 0.000 abstract 4
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 241001465754 Metazoa Species 0.000 abstract 2
- 208000028774 intestinal disease Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 244000005700 microbiome Species 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 241001239379 Calophysus macropterus Species 0.000 abstract 1
- 101100424487 Escherichia coli (strain K12) tamA gene Proteins 0.000 abstract 1
- 101100424491 Escherichia coli (strain K12) tamB gene Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 101150068991 flhB gene Proteins 0.000 abstract 1
- 101150026424 fliR gene Proteins 0.000 abstract 1
- 101150065098 glnG gene Proteins 0.000 abstract 1
- -1 glnH Proteins 0.000 abstract 1
- 230000004727 humoral immunity Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 101150052329 motA gene Proteins 0.000 abstract 1
- 101150110871 motB gene Proteins 0.000 abstract 1
- 101150012415 ntrC gene Proteins 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 101150092975 tlyC gene Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPR1381A AUPR138100A0 (en) | 2000-11-10 | 2000-11-10 | Novel therapeutic compositions for treating infection by lawsonia spp |
| US24959600P | 2000-11-17 | 2000-11-17 | |
| PCT/AU2001/001462 WO2002038594A1 (fr) | 2000-11-10 | 2001-11-09 | Nouvelles compositions therapeutiques pour traiter une infection par lawsonia spp |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0114835A true BR0114835A (pt) | 2003-07-01 |
Family
ID=25646507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0114835-4A BR0114835A (pt) | 2000-11-10 | 2001-11-09 | Composições terapêuticas para tratamento de infecção por lawsonia spp |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1332154A4 (fr) |
| JP (1) | JP2004512851A (fr) |
| BR (1) | BR0114835A (fr) |
| CA (1) | CA2399276A1 (fr) |
| MX (1) | MXPA03003077A (fr) |
| NZ (1) | NZ520600A (fr) |
| WO (1) | WO2002038594A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003295341A1 (en) * | 2002-10-04 | 2004-05-04 | Regents Of The University Of Minnesota | Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using |
| US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| US8398994B2 (en) | 2005-07-15 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia vaccine and methods of use thereof |
| US20100129397A1 (en) | 2006-12-11 | 2010-05-27 | Boehringer Ingelheim Vetmedica, Inc. | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
| FR2980213B1 (fr) * | 2011-09-16 | 2013-09-06 | Biomerieux Sa | Procede de caracterisation de bacteries, par detection de proteines non-structurales de bacteriophages |
| US9359643B2 (en) | 2013-03-08 | 2016-06-07 | Progenika Biopharma S.A. | Discrimination of blood type variants |
| CL2017002196A1 (es) | 2017-08-30 | 2017-11-17 | Univ De Concepción | Vacuna recombinante contra enteropatía proliferativa en animales. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5885823A (en) * | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| CN1145697C (zh) * | 1995-11-30 | 2004-04-14 | 维多利亚农业服务控股公司 | 治疗和诊断组合物 |
| CA2328141A1 (fr) * | 1998-05-12 | 1999-11-18 | Smithkline Beecham Biologicals S.A. | Composes derives de moraxella catarrhalis |
| TWI224107B (en) * | 1998-10-22 | 2004-11-21 | Pfizer Prod Inc | Novel proteins from actinobacillus pleuropneumoniae |
| GB9902880D0 (en) * | 1999-02-09 | 1999-03-31 | Smithkline Beecham Biolog | Novel compounds |
-
2001
- 2001-11-09 EP EP01983297A patent/EP1332154A4/fr not_active Withdrawn
- 2001-11-09 WO PCT/AU2001/001462 patent/WO2002038594A1/fr not_active Application Discontinuation
- 2001-11-09 MX MXPA03003077A patent/MXPA03003077A/es unknown
- 2001-11-09 BR BR0114835-4A patent/BR0114835A/pt not_active IP Right Cessation
- 2001-11-09 CA CA002399276A patent/CA2399276A1/fr not_active Abandoned
- 2001-11-09 JP JP2002541925A patent/JP2004512851A/ja active Pending
- 2001-11-09 NZ NZ520600A patent/NZ520600A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004512851A (ja) | 2004-04-30 |
| EP1332154A1 (fr) | 2003-08-06 |
| NZ520600A (en) | 2004-08-27 |
| CA2399276A1 (fr) | 2002-05-16 |
| WO2002038594A9 (fr) | 2002-11-07 |
| MXPA03003077A (es) | 2003-09-25 |
| EP1332154A4 (fr) | 2005-05-11 |
| WO2002038594A1 (fr) | 2002-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cawthraw et al. | Increased colonization potential of Campylobacter jejuni strain 81116 after passage through chickens and its implication on the rate of transmission within flocks | |
| NO20111324A1 (no) | Rekombinant MVA-virus | |
| ATE329031T1 (de) | Therapeutische zusammensetzungen zur behandlung von lawsonia intracellularis infektionen | |
| US10704027B2 (en) | Bacteriophage and antibacterial composition comprising the same | |
| WO2014133290A1 (fr) | Nouveau bactériophage et composition antibactérienne comprenant celui-ci | |
| WO2014133323A1 (fr) | Nouveau bactériophage et composition antibactérienne le comprenant | |
| DE60316772D1 (de) | Von menschen oder tieren verwenbare diätetische und/oder pharmazeutische zubereitungen, auf basis von probiotischen mikroorganismen | |
| DK1185660T3 (da) | Svinecircovirus-vaccine i rekombinant poxvirus | |
| ATE366312T1 (de) | Impfstoff und antitoxine zur behandlung und vorbeugung von c. difficile krankheiten | |
| EP1854886A3 (fr) | Virus de la grippe pour les chevaux adaptés au froid | |
| WO2014133322A1 (fr) | Nouveau bactériophage et composition antibactérienne comprenant celui-ci | |
| WO2014133289A1 (fr) | Nouveau bactériophage et composition antibactérienne le comprenant | |
| BR9910749A (pt) | Composições e vacinas imunogênicas combinadas para meningites b e c e método de induzir uma resposta imune por administração da mesma | |
| BR0114835A (pt) | Composições terapêuticas para tratamento de infecção por lawsonia spp | |
| MX2012003827A (es) | Toxina rtx citolitica de gallibacterium anatis. | |
| BR0011292A (pt) | Gene derivado de lawsonia e proteìnas, peptìdeos e polipeptìdeos sodc relacionados e seus usos | |
| NZ515330A (en) | Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses | |
| US20190015495A1 (en) | Vaccine strains of brachyspira hyodysenteriae | |
| BR0011294A (pt) | Gene derivado lawsonia e polipeptìdeos, peptìdeos e proteìnas flge relacionados e seus usos | |
| BR0007966A (pt) | Composições e métodos para o tratamento e a prevenção de infecção bacteriana patogênica com base na função essencial da metilação do dna na virulência bacteriana | |
| Lentsch et al. | Combining oral vaccination and niche competition to fight antimicrobial resistance gene reservoirs | |
| WO2023066229A3 (fr) | Protéine e2 du virus de la peste porcine classique de recombinaison ayant une permutation de domaine b/c | |
| Chattopadhayay | New born chicks can serve as an experimental animal model for human campylobacteriosis | |
| Herman et al. | Study of the pathogenic factors produced by Actinobacillus pleuropneumoniae. | |
| UA65104A (en) | Clostridium perfringens c type strain used for production of vaccines against anaerobic infections of livestock |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2021 DE 29/09/2009. |